The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma.

Sakaguchi, Tatsuma; Satoi, Sohei; Yamamoto, Tomohisa; Yamaki, So; Sekimoto, Mitsugu

Sakaguchi, Tatsuma; Satoi, Sohei; Yamamoto, Tomohisa; Yamaki, So; Sekimoto, Mitsugu.

Afiliação

Sakaguchi T; Department of Surgery, Kansai Medical University, 2-3-1, Shin-machi, Hirakata, Osaka, 573-1191, Japan.
Satoi S; Department of Surgery, Kansai Medical University, 2-3-1, Shin-machi, Hirakata, Osaka, 573-1191, Japan. satoi@hirakata.kmu.ac.jp.
Yamamoto T; Department of Surgery, Kansai Medical University, 2-3-1, Shin-machi, Hirakata, Osaka, 573-1191, Japan.
Yamaki S; Department of Surgery, Kansai Medical University, 2-3-1, Shin-machi, Hirakata, Osaka, 573-1191, Japan.
Sekimoto M; Department of Surgery, Kansai Medical University, 2-3-1, Shin-machi, Hirakata, Osaka, 573-1191, Japan.

Surg Today ; 50(4): 335-343, 2020 Apr.

Article em En | MEDLINE | ID: mdl-31993761

Assuntos

Carcinoma Ductal Pancreático/cirurgia; Terapia Combinada/tendências; Neoplasias Pancreáticas/cirurgia; Humanos; Terapia Neoadjuvante

Palavras-chave

Borderline resectable; Multimodality treatment; Pancreatic ductal adenocarcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Terapia Combinada / Carcinoma Ductal Pancreático Limite: Humans Idioma: En Revista: Surg Today Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google